Oncocyte Corp Quarterly Selling and Marketing Expense in USD from Q1 2016 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate total amount of expenses directly related to the marketing or selling of products or services.
Summary
Oncocyte Corp quarterly/annual Selling and Marketing Expense history and growth rate from Q1 2016 to Q2 2024.
  • Oncocyte Corp Selling and Marketing Expense for the quarter ending June 30, 2024 was $853K, a 5.96% increase year-over-year.
  • Oncocyte Corp Selling and Marketing Expense for the twelve months ending June 30, 2024 was $2.99M, a 33.7% increase year-over-year.
  • Oncocyte Corp annual Selling and Marketing Expense for 2023 was $2.8M, a 147% increase from 2022.
  • Oncocyte Corp annual Selling and Marketing Expense for 2022 was $1.13M, a 105% increase from 2021.
  • Oncocyte Corp annual Selling and Marketing Expense for 2021 was $552K, a 91.5% decline from 2020.
Selling and Marketing Expense, Trailing 12 Months (USD)
Selling and Marketing Expense, Quarterly (USD)
Selling and Marketing Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $2.99M $853K +$48K +5.96% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $2.95M $846K +$151K +21.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q4 2023 $2.8M $582K +$248K +74.3% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-16
Q3 2023 $2.55M $713K +$308K +76% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $2.24M $805K +$678K +534% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $1.56M $695K +$429K +161% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $1.13M $334K -$2.98M -89.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-16
Q3 2022 $4.11M $405K -$2.53M -86.2% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $6.63M $127K -$2.55M -95.2% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 $9.18M $266K -$1.99M -88.2% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 $11.2M $3.31M +$1.44M +76.6% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-11
Q3 2021 $9.73M $2.93M +$1.36M +86.9% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $8.37M $2.67M +$1.11M +71.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 $7.26M $2.25M +$764K +51.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q4 2020 $6.49M $1.87M +$863K +85.4% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-11
Q3 2020 $5.63M $1.57M +$938K +149% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-11
Q2 2020 $4.69M $1.56M +$1.24M +391% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-11
Q1 2020 $3.45M $1.49M +$1.29M +627% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-11
Q4 2019 $2.16M $1.01M +$741K +274% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-19
Q3 2019 $1.42M $630K +$446K +242% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $977K $318K -$251K -44.1% Apr 1, 2019 Jun 30, 2019 10-Q 2020-07-29
Q1 2019 $1.23M $205K -$453K -68.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-12
Q4 2018 $1.68M $270K -$331K -55.1% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-26
Q3 2018 $2.01M $184K -$526K -74.1% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $2.54M $569K +$92K +19.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-14
Q1 2018 $2.45M $658K +$3K +0.46% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-14
Q4 2017 $2.44M $601K +$57K +10.5% Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $2.39M $710K +$554K +355% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $1.83M $477K +$207K +76.7% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $1.63M $655K +$427K +187% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 $1.2M $544K Oct 1, 2016 Dec 31, 2016 10-K 2018-04-02
Q3 2016 $156K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $270K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $228K Jan 1, 2016 Mar 31, 2016 10-Q 2017-04-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.